Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Dupuytren's disease].

R Trèves1

  • 1Service de Rhumatologie et Thérapeutique, CHU Guillaume Dupuytren, Limoges, France. richard.treves@unilim.fr

Reumatismo
|October 3, 2006
PubMed
Summary
This summary is machine-generated.

Dupuytren's disease involves progressive hand deformity due to palmar aponeurosis fibrosis. This summary covers the disease's clinical features and therapeutic considerations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Fertility preservation in cancer women: a multidisciplinary approach].

Journal de gynecologie, obstetrique et biologie de la reproduction·2011
Same author

[In vitro maturation of oocytes: an option for fertility preservation in women].

Journal de gynecologie, obstetrique et biologie de la reproduction·2011
Same author

Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis.

Annals of the rheumatic diseases·2007
Same author

[Obligatory information of patients with rheumatic illness (300 cases)].

Bulletin de l'Academie nationale de medecine·2005
Same author

Management of osteoarthritis (OA) with an unsupervised home based exercise programme and/or patient administered assessment tools. A cluster randomised controlled trial with a 2x2 factorial design.

Annals of the rheumatic diseases·2004
Same author

Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot study.

Clinical and experimental rheumatology·2003
Same journal

Delayed referral, socioeconomic status, and disease characteristics as factors associated with disabilities in rheumatoid arthritis patients: a multicenter observational study.

Reumatismo·2026
Same journal

Telerheumatology to improve first access outcomes in outpatients: a prospective monocentric pilot study.

Reumatismo·2026
Same journal

Hypocomplementemic urticarial vasculitis: a rare presentation revealing systemic lupus erythematosus and Sjögren's disease.

Reumatismo·2026
Same journal

Is there still someone laughing at Christopher Columbus?

Reumatismo·2026
Same journal

Concurrent herpetic hypertensive anterior uveitis and cytomegalovirus retinitis in a non-HIV patient with melanoma differentiation-associated gene-5 dermatomyositis: intravenous immunoglobulin comes to the rescue.

Reumatismo·2026
Same journal

Myasthenic syndrome in systemic lupus erythematosus successfully treated with plasma exchange: through one of the unexplored faces of neuropsychiatric involvement.

Reumatismo·2026
See all related articles

Area of Science:

  • Orthopedics
  • Hand Surgery
  • Fibrotic Diseases

Background:

  • Dupuytren's disease is a condition characterized by the progressive tightening and thickening of the palmar fascia, leading to finger contractures.
  • The condition results in flexion deformities of the fingers, significantly impacting hand function and patient quality of life.

Discussion:

  • This note provides a brief biography of the French surgeon Guillaume Dupuytren, who first described the disease in 1831.
  • Key clinical manifestations of Dupuytren's disease are detailed, focusing on the characteristic progressive flexion deformities.

Key Insights:

  • Understanding the etiology of palmar aponeurosis fibrosis is crucial for managing Dupuytren's disease.
  • Early recognition of clinical features aids in timely diagnosis and intervention.

Related Experiment Videos

Outlook:

  • Further research into the underlying fibrotic mechanisms may reveal novel therapeutic targets.
  • Exploring and refining current therapeutic strategies is essential for improving patient outcomes in Dupuytren's disease.